Reply
Hepatology
.
2020 Jan;71(1):399-400.
doi: 10.1002/hep.30963.
Epub 2020 Jan 3.
Authors
Elizabeth C Goode
1
2
3
4
5
,
Gideon M Hirschfield
6
7
8
9
,
Simon M Rushbrook
1
4
Affiliations
1
Norfolk and Norwich University Hospital, Norwich, United Kingdom.
2
Academic Department of Medical Genetics, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
3
Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
4
Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
5
Cambridge Transplant Centre, Addenbrooke's Hospital, Cambridge, United Kingdom.
6
National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, United Kingdom.
7
Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
8
Centre for Rare Diseases, Institute of Translational Medicine, University Hospitals Birmingham, Birmingham, United Kingdom.
9
Toronto Centre for Liver Disease, University Health Network and University of Toronto, Toronto, Canada.
PMID:
31550385
DOI:
10.1002/hep.30963
No abstract available
Publication types
Letter
Comment
MeSH terms
Cholangitis, Sclerosing*
Humans